CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,284 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05737875
NCT05737875N/ACompleted
CompareCT.gov

DISPAIR vs. D-FRS - Establishing the Superiority of the Novel Distal Pancreatectomy Pancreatic Fistula Risk Prediction Models - A Multicenter International Retrospective Validation Study

University of Edinburgh·observational·Posted Feb 21, 2023·Updated Jul 8, 2025

In Brief

An observational study for Pancreatic Fistula and Pancreatectomy. Completed, enrolled 2,284 participants across 1 site.

Detailed Summary

Distal pancreas resection is a relatively rare procedure with a known risk of postoperative pancreatic fistula. Until quite recently, no valid risk prediction models for this have been available. In 2022 two different risk scores DISPAIR and D-FRS were published. The aim of this study is to compare, validate and possibly improve those scores in a international retrospective multicenter cohort.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Fistula, Pancreatectomy
CountriesUnited Kingdom
CollaboratorsHelsinki University Central Hospital, NHS Lothian, Royal Infirmary of Edinburgh

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 21, 2023
Enrollment StartApr 7, 2023
Primary CompletionApr 6, 2025
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 3.4 years ago